Polycystic Ovarian Syndrome/Disease (PCOS/PCOD) Market

By Diagnosis (Pelvic Examination, Ultrasound, Blood Test),
By Drug Class (Oral Contraceptives, Insulin Sensitizing Agents, Antiandrogens, Ornithine Decarboxylase Inhibitors, Aromatase Inhibitors & SERMs, Others),
By Distribution and Usage (Hospitals, Pharmacies, and Drug Stores, e-commerce, Clinics),
By Surgery (Wedge Resection, Laparoscopic Drilling),
By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa):

Global Analysis and Forecast 2023-2033

Base Year
2022
|
Forecast Timeframe:
2023 to 2033
|
Data Tables:
268
|
Number of Figures
163
|
Expert Contributions

The global polycystic ovarian syndrome/disease (PCOS/PCOD) market showcased a revenue of USD 3,101.6 Million in 2022 and is projected to witness a compounded annual growth rate (CAGR) of more than 4% over the forecast period of 2023-2033.

1.      Introduction

1.1    Report Description

1.1.1 Definition

1.1.2 Abbreviations

1.2    Key Market Segments

1.3    Benefits to Stakeholders

1.4    Research Methodology

1.4.1 Market Scoping

1.4.1.1   Problem Identification
1.4.1.2   Defining the Market

1.4.2 Market Estimation

1.4.2.1   Data Mining
1.4.2.2   Product Analysis
1.4.2.3   Application Analysis
1.4.2.4   Market Engineering and Forecasting
1.4.2.4.1  Bottom-up Demand Side
1.4.2.4.2  Bottom-up Supply side

1.4.3 Market Authentication

1.4.3.1   Data Triangulation
1.4.3.1.1  Top-down Supply Side
1.4.3.1.2  Top-down Demand Side
1.4.3.1.3  Data Triangulation
1.4.3.2   Primary Insights and Industry feedback

1.4.4 Report Writing

2. Executive Summary

2.1 Market Snapshot

2.2 Macro Trends, Global Economic Factors and Import/Export Insights

2.3 Primary Insights

2.4 PCOD/PCOS Diagosis Insights

2.5 PCOD/PCOS Drug Class Insights

2.6 PCOD/PCOS Distribution & Usage Insights

2.7 PCOD/PCOS Surgery Insights

2.8 Regional Insights

3. Market Overview

3.1 Market Segment and Scope

3.2 Top Investment Pockets

3.3 Key Strategic Initiatives

3.4 Polycystic Ovarian Syndrome/Disease (PCOS/PCOD) Market Industry Ecosystem

3.5 Market Evolution

3.6 Patent Analysis

3.7 Technology Landscape

3.8 Regulatory Infrastructure

3.9 Porter’s Analysis

3.9.1 Bargaining Power of Buyer

3.9.2 Bargaining Power of Supplier

3.9.3 Threat of New Entrants

3.9.4 Threat of Substitutes

3.9.5 Industry Rivalry

3.10 PESTLE Analysis

3.11 Market Dynamics

3.11.1 Drivers

3.11.2 Restrains

3.11.3 Opportunities

3.12 Impact of COVID-19 on Polycystic Ovarian Syndrome/Disease (PCOS/PCOD) Market

3.13 Russia-Ukraine War Impact on Polycystic Ovarian Syndrome/Disease (PCOS/PCOD) Market

3.14 Growth Share Matrix

3.15 Polycystic Ovarian Syndrome/Disease (PCOS/PCOD) Market Quadrant

4. Polycystic Ovarian Disease/Syndrome (PCOD/PCOS) Market, By Diagnosis

4.1 Major Impacting Factors, By Diagnosis

4.1.1 Key Market Trends and Growth Factors

4.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Million)

4.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Million)

4.2 Pelvic Examination

4.2.1 Key Market Trends and Growth Factors

4.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Million)

4.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Million)

4.3 Ultrasound

4.3.1 Key Market Trends and Growth Factors

4.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Million)

4.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Million)

4.4 Blood Test

4.4.1 Key Market Trends and Growth Factors

4.4.2 Market Size and Forecast, by Region, 2018-2033, (USD Million)

4.4.3 Market Size and Forecast, by Country, 2018-2033, (USD Million)

5. Polycystic Ovarian Disease/Syndrome (PCOD/PCOS) Market, By Drug Class

5.1 Major Impacting Factors, By Drug Class

5.1.1 Key Market Trends and Growth Factors

5.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Million)

5.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Million)

5.2 Oral Contraceptives

5.2.1 Key Market Trends and Growth Factors

5.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Million)

5.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Million)

5.3 Insulin Sensitizing Agents

5.3.1 Key Market Trends and Growth Factors

5.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Million)

5.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Million)

5.4 Antiandrogens

5.4.1 Key Market Trends and Growth Factors

5.4.2 Market Size and Forecast, by Region, 2018-2033, (USD Million)

5.4.3 Market Size and Forecast, by Country, 2018-2033, (USD Million)

5.5 Ornithine Decarboxylase Inhibitors

5.5.1 Key Market Trends and Growth Factors

5.5.2 Market Size and Forecast, by Region, 2018-2033, (USD Million)

5.5.3 Market Size and Forecast, by Country, 2018-2033, (USD Million)

5.6 Aromatase Inhibitors & SERMs

5.6.1 Key Market Trends and Growth Factors

5.6.2 Market Size and Forecast, by Region, 2018-2033, (USD Million)

5.6.3 Market Size and Forecast, by Country, 2018-2033, (USD Million)

5.7 Others

5.7.1 Key Market Trends and Growth Factors

5.7.2 Market Size and Forecast, by Region, 2018-2033, (USD Million)

5.7.3 Market Size and Forecast, by Country, 2018-2033, (USD Million)

6. Polycystic Ovarian Disease/Syndrome (PCOD/PCOS) Market, By Distribution and Usage

6.1 Major Impacting Factors, By Distribution and Usage

6.1.1 Key Market Trends and Growth Factors

6.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Million)

6.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Million)

6.2 Hospitals

6.2.1 Key Market Trends and Growth Factors

6.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Million)

6.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Million)

6.3 Pharmacies and Drug Stores

6.3.1 Key Market Trends and Growth Factors

6.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Million)

6.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Million)

6.4 e-commerce

6.4.1 Key Market Trends and Growth Factors

6.4.2 Market Size and Forecast, by Region, 2018-2033, (USD Million)

6.4.3 Market Size and Forecast, by Country, 2018-2033, (USD Million)

6.5 Clinics

6.5.1 Key Market Trends and Growth Factors

6.5.2 Market Size and Forecast, by Region, 2018-2033, (USD Million)

6.5.3 Market Size and Forecast, by Country, 2018-2033, (USD Million)

7. Polycystic Ovarian Disease/Syndrome (PCOD/PCOS) Market, By Surgery

7.1 Major Impacting Factors, By Surgery

7.1.1 Key Market Trends and Growth Factors

7.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Million)

7.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Million)

7.2 Wedge Resection

7.2.1 Key Market Trends and Growth Factors

7.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Million)

7.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Million)

7.3 Laparoscopic Drilling

7.3.1 Key Market Trends and Growth Factors

7.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Million)

7.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Million)

8. Polycystic Ovarian Disease/Syndrome (PCOD/PCOS) Market, By Region

8.1 Global Market Trends and Growth Factors

8.2 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)

8.3 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)

8.4 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)

8.5 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.6 Market Size and Forecast, by Region, 2018-2033, (USD Million)

8.7 North America

8.7.1 Key Market Trends and Growth Factors

8.7.2 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)

8.7.3 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)

8.7.4 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)

8.7.5 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.7.6 Market Size and Forecast, by Country, 2018-2033, (USD Million)

8.7.7 U.S.

8.7.7.1 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)
8.7.7.2 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)
8.7.7.3 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)
8.7.7.4 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.7.8 Canada

8.7.8.1 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)
8.7.8.2 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)
8.7.8.3 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)
8.7.8.4 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.7.9 Mexico

8.7.9.1 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)
8.7.9.2 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)
8.7.9.3 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)
8.7.9.4 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.8 Europe

8.8.1 Key Market Trends and Growth Factors

8.8.2 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)

8.8.3 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)

8.8.4 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)

8.8.5 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.8.6 Market Size and Forecast, by Country, 2018-2033, (USD Million)

8.8.7 UK

8.8.7.1 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)
8.8.7.2 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)
8.8.7.3 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)
8.8.7.4 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.8.8 Germany

8.8.8.1 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)
8.8.8.2 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)
8.8.8.3 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)
8.8.8.4 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.8.9 France

8.8.9.1 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)
8.8.9.2 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)
8.8.9.3 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)
8.8.9.4 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.8.10 Russia

8.8.10.1 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)
8.8.10.2 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)
8.8.10.3 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)
8.8.10.4 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.8.11 Italy

8.8.11.1 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)
8.8.11.2 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)
8.8.11.3 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)
8.8.11.4 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.8.12 Rest of Europe

8.8.12.1 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)
8.8.12.2 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)
8.8.12.3 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)
8.8.12.4 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.9 Asia-Pacific

8.9.1 Key Market Trends and Growth Factors

8.9.2 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)

8.9.3 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)

8.9.4 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)

8.9.5 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.9.6 Market Size and Forecast, by Country, 2018-2033, (USD Million)

8.9.7 China

8.9.7.1 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)
8.9.7.2 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)
8.9.7.3 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)
8.9.7.4 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.9.8 India

8.9.8.1 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)
8.9.8.2 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)
8.9.8.3 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)
8.9.8.4 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.9.9 Japan

8.9.9.1 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)
8.9.9.2 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)
8.9.9.3 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)
8.9.9.4 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.9.10 Australia

8.9.10.1 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)
8.9.10.2 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)
8.9.10.3 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)
8.9.10.4 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.9.11 Rest of Asia-Pacific

8.9.11.1 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)
8.9.11.2 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)
8.9.11.3 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)
8.9.11.4 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.10 Latin America

8.10.1 Key Market Trends and Growth Factors

8.10.2 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)

8.10.3 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)

8.10.4 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)

8.10.5 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.10.6 Market Size and Forecast, by Country, 2018-2033, (USD Million)

8.10.7 Brazil

8.10.7.1 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)
8.10.7.2 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)
8.10.7.3 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)
8.10.7.4 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.10.8 Argentina

8.10.8.1 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)
8.10.8.2 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)
8.10.8.3 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)
8.10.8.4 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.10.9 Mexico

8.10.9.1 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)
8.10.9.2 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)
8.10.9.3 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)
8.10.9.4 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.10.10 Chile

8.10.10.1 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)
8.10.10.2 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)
8.10.10.3 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)
8.10.10.4 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.11 Middle East and Africa

8.11.1 Key Market Trends and Growth Factors

8.11.2 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)

8.11.3 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)

8.11.4 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)

8.11.5 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.11.6 Market Size and Forecast, by Country, 2018-2033, (USD Million)

8.11.7 South Africa

8.11.7.1 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)
8.11.7.2 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)
8.11.7.3 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)
8.11.7.4 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.11.8 UAE

8.11.8.1 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)
8.11.8.2 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)
8.11.8.3 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)
8.11.8.4 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.11.9 Saudi Arabia

8.11.9.1 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)
8.11.9.2 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)
8.11.9.3 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)
8.11.9.4 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

8.11.10 Israel

8.11.10.1 Market Size and Forecast, by Diagnosis, 2018-2033, (USD Million)
8.11.10.2 Market Size and Forecast, by Drug Class, 2018-2033, (USD Million)
8.11.10.3 Market Size and Forecast, by Distribution and Usage, 2018-2033, (USD Million)
8.11.10.4 Market Size and Forecast, by Surgery, 2018-2033, (USD Million)

9. Competitive Benchmarking & Company Profiles

9.1 Competitive Benchmarking

9.1.1 Company Market Share

9.1.2 Product Mapping

9.1.3 Competitive Heat map

9.2 Allergan

9.2.1 Company Overview

9.2.2 Financial Analysis

9.2.3 Product Offering

9.2.4 Strategic Initiatives

9.2.5 SWOT

9.2.6 Ansoff Matrix

9.3 Apothecus Pharmaceutical Cor

9.3.1 Company Overview

9.3.2 Financial Analysis

9.3.3 Product Offering

9.3.4 Strategic Initiatives

9.3.5 SWOT

9.3.6 Ansoff Matrix

9.4 Amgen

9.4.1 Company Overview

9.4.2 Financial Analysis

9.4.3 Product Offering

9.4.4 Strategic Initiatives

9.4.5 SWOT

9.4.6 Ansoff Matrix

9.5 Blairex Laboratories Inc

9.5.1 Company Overview

9.5.2 Financial Analysis

9.5.3 Product Offering

9.5.4 Strategic Initiatives

9.5.5 SWOT

9.5.6 Ansoff Matrix

9.6 Bristol-Myers Squibb Company

9.6.1 Company Overview

9.6.2 Financial Analysis

9.6.3 Product Offering

9.6.4 Strategic Initiatives

9.6.5 SWOT

9.6.6 Ansoff Matrix

9.7 Johnson & Johnson Services, Inc

9.7.1 Company Overview

9.7.2 Financial Analysis

9.7.3 Product Offering

9.7.4 Strategic Initiatives

9.7.5 SWOT

9.7.6 Ansoff Matrix

9.8 JSC BIOCAD

9.8.1 Company Overview

9.8.2 Financial Analysis

9.8.3 Product Offering

9.8.4 Strategic Initiatives

9.8.5 SWOT

9.8.6 Ansoff Matrix

9.9 Novartis A

9.9.1 Company Overview

9.9.2 Financial Analysis

9.9.3 Product Offering

9.9.4 Strategic Initiatives

9.9.5 SWOT

9.9.6 Ansoff Matrix

9.10 Teva Pharmaceutical Industries

9.10.1 Company Overview

9.10.2 Financial Analysis

9.10.3 Product Offering

9.10.4 Strategic Initiatives

9.10.5 SWOT

9.10.6 Ansoff Matrix

9.11 Teva Pharmaceutical Industries

9.11.1 Company Overview

9.11.2 Financial Analysis

9.11.3 Product Offering

9.11.4 Strategic Initiatives

9.11.5 SWOT

9.11.6 Ansoff Matrix

10. Industry Connects and Upcoming Seminars

REPORT CODE
HCP22007
PUBLISHED ON
July 2023
REQUEST A FREE SAMPLE
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
BUY NOW
SCHEDULE A CONSULTING CALL